A 37-year-old spinal cord-injured female patient, transplanted of multipotent stem cells from human UC blood, with improved sensory perception and mobility, both functionally and morphologically: a case study.

@article{Kang2005A3S,
  title={A 37-year-old spinal cord-injured female patient, transplanted of multipotent stem cells from human UC blood, with improved sensory perception and mobility, both functionally and morphologically: a case study.},
  author={Kyung-Sun Kang and S W Kim and Young-Hak Oh and J. W. Yu and K.-Y. Kim and H. K. Park and Chunhua Song and H Han},
  journal={Cytotherapy},
  year={2005},
  volume={7 4},
  pages={
          368-73
        }
}
HLA-matched UC blood-derived multipotent stem cells were directly transplanted into the injured spinal cord site of a 37-year-old female patient suffering from spinal cord injury (SPI). In this case, human cord blood (UCB)-derived multipotent stem cells improved sensory perception and movement in the SPI patient's hips and thighs within 41 days of cell transplantation. CT and MRI results also showed regeneration of the spinal cord at the injured site and some of the cauda equina below it… 

Figures and Tables from this paper

Treatment of chronic spinal cord injured patients with autologous bone marrow-derived hematopoietic stem cell transplantation: 1-year follow-up.

TLDR
Autologous hematopoietic progenitor stem cells are used in order to avoid the problems associated with immunologic rejection and graft-versus-host (GvH) reactions, which are frequently caused by allografts.

Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study.

TLDR
The results indicate that the protocol is safe with no serious adverse events following transplantation in SCI patients, and encourage further trials with higher doses and different routes of administration in order to demonstrate the recovery/efficacy if any, inSCI patients.

Feasibility of combination allogeneic stem cell therapy for spinal cord injury: a case report

TLDR
The case of 29 year old male who suffered a crush fracture of the L1 vertebral body, lacking lower sensorimotor function, being a score A on the ASIA scale is reported, which supports further investigation into allogeneic-based stem cell therapies for SCI.

Continuous Improvement after Multiple Mesenchymal Stem Cell Transplantations in a Patient with Complete Spinal Cord Injury

TLDR
It is suggested that repeated intrathecal infusions of MSCs might have the potential to produce clinically meaningful improvements for SCI patients.

A comparison of autologous and allogenic bone marrow-derived mesenchymal stem cell transplantation in canine spinal cord injury

Potential role of stem cells in severe spinal cord injury: current perspectives and clinical data

TLDR
Application of cell-based strategies for the repair and regeneration of the chronically injured spinal cord will require a combinational strategy that may need to include approaches to overcome the effects of the glial scar, inhibitory molecules, and use of tissue engineering strategies to bridge the lesion.

Spinal cord injury regeneration using autologous bone marrow-derived neurocytes and rat embryonic stem cells: A comparative study in rats

TLDR
This study provided strong evidence to support that transplantation of rESC and ABMDN can improve functional recovery after iatrogenic SCI and the transplanted cells showed a beneficial therapeutic effect when compared to the control group.

Transplantation of Umbilical Cord Blood Stem Cells for Treating Spinal Cord Injury

TLDR
The recent findings on the stemness properties and the therapeutic potential of hUCB as a safe, feasible and effective cellular source for transplantation in SCI are presented.

BENEFICIAL EFFECTS OF BONE MARROW DERIVED MESENCHYMAL STEM CELLS ( BM-MSC ) IN FUNCTIONAL RESTORATION OF CHRONIC SPINAL CORD INJURY EXPERIMENTALLY INDUCED IN MALE ALBINO RATS : COMPARISON OF INTRAVENOUS AND INTRALESIONAL ROUTS OF

TLDR
Bone marrowderived mesenchymal stem cell transplantation has a promising role in functional restoration of the spinal cord in rats after chronic spinal cord injury especially with the intralesional route of injection.
...

References

SHOWING 1-10 OF 24 REFERENCES

Rapid neural differentiation of human cord blood-derived mesenchymal stem cells

TLDR
The neurogenic potential of UCB-derived stem cells may facilitate stem cell therapeutic approaches to neurodegenerative diseases and improve the prospects for cell transplantation and cell therapy.

Age‐Related Osteogenic Potential of Mesenchymal Stromal Stem Cells from Human Vertebral Bone Marrow

TLDR
It is demonstrated that the number of MSCs with osteogenic potential (CFU‐F/ALP+) decreases early during aging in humans and may be responsible for the age‐related reduction in osteoblast number.

Adult bone marrow is a rich source of human mesenchymal ‘stem’ cells but umbilical cord and mobilized adult blood are not

TLDR
It is concluded that adult BM is a reliable source of functional cultured MSC, but CB and PBSC are not.

Human Umbilical Cord Blood as a Source of Transplantable Hepatic Progenitor Cells

TLDR
It is demonstrated that human UCB is a source of transplantable hepatic progenitor cells and may have relevance to clinical application of UCB‐derived cell transplantation as a novel therapeutic option for liver failure.

Skeletal Myogenic Differentiation of Mesenchymal Stem Cells Isolated from Human Umbilical Cord Blood

TLDR
The results demonstrate that UCB‐derived MSCs possess a potential of skeletal myogenic differentiation and also imply that these cells could be a suitable source for skeletal muscle repair and a useful tool of muscle‐related tissue engineering.

Searching for Alternative Sources of Postnatal Human Mesenchymal Stem Cells: Candidate MSC‐Like Cells from Umbilical Cord

TLDR
An attempt to isolate MSCs from the subendothelial layer of umbilical cord vein using two standard methodological approaches and results suggest that cord vasculature contains a high number of MSC‐like elements forming colonies of fibroblastoid cells that may be successfully expanded in culture.

Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells.

TLDR
It was determined that granulocyte-macrophage, erythroid, and multipotential progenitor cells remained functionally viable in cord blood untreated except for addition of anticoagulant for at least 3 days at 4 degrees C or 25 degrees C (room temperature), though not at 37 degrees C, implying that these cells could be satisfactorily studied and used or cryopreserved for therapy.

Isolation of multipotent mesenchymal stem cells from umbilical cord blood.

TLDR
Surprisingly, these cells were also able to differentiate into neuroglial- and hepatocyte-like cells under appropriate induction conditions and, thus, they may be more than mesenchymal stem cells as evidenced by their ability to differentiation into cell types of all 3 germ layers.